RTSN Retension Pharmaceuticals, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $370K and sold $0 on the open market.
Recent RTSN insider trades
- Oct 13, 2026: Keller Eric L. bought 20,800 shares ($250K)
- Oct 13, 2026: Berger Franklin M bought 10,000 shares ($120K)
5%+ owners
- The B Group, Inc.: 10.0% (Schedule 13G, filed Oct 16, 2026)
- PVG ASSET MANAGEMENT CORP: 8.3% (Schedule 13G, filed Oct 16, 2026)
- Laurence W. Lytton: 7.4% (Schedule 13G, filed Oct 15, 2026)
- Eric Keller: 7.1% (Schedule 13D, filed Oct 14, 2026)
Are insiders buying or selling RTSN?
Over the last 12 months insiders bought $370K and sold $0 of Retension Pharmaceuticals, Inc. stock on the open market (SEC Form 4).